Tracy Ann Perry

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi Pyridoxine-induced toxicity in rats: a stereological quantification of the sensory neuropathy
    Tracy Ann Perry
    Section of Drug Design and Development, Laboratory of Neurosciences, Gerontology Research Center, National Institute on Aging NIH, 5600 Nathan Shock Drive, Baltimore, MD 21224, USA
    Exp Neurol 190:133-44. 2004
  2. ncbi Thalidomide-based TNF-alpha inhibitors for neurodegenerative diseases
    Nigel H Greig
    Drug Design and Development Section, Lab of Neurosciences, Intramural Research Prog, National Inst on Aging, National Inst of Health, 5600 Nathan Shock Dr, Baltimore, MD 21224, USA
    Acta Neurobiol Exp (Wars) 64:1-9. 2004
  3. ncbi Thiothalidomides: novel isosteric analogues of thalidomide with enhanced TNF-alpha inhibitory activity
    Xiaoxiang Zhu
    Drug Design and Development Section, Laboratory of Neurosciences, Gerontology Research Center (4E02, Intramural Research Program, National Institute on Aging, National Institutes of Health, 5600 Nathan Shock Dr, Baltimore, Maryland 21224-6825, USA
    J Med Chem 46:5222-9. 2003
  4. ncbi A new Alzheimer's disease interventive strategy: GLP-1
    Tracy Ann Perry
    Drug Design and Development Section, Laboratory of Neurosciences, Gerontology Research Center, Intramural Research Program National Institute on Aging, National Institutes of Health, 5600 Nathan Shock Drive, Baltimore, MD 21224, USA
    Curr Drug Targets 5:565-71. 2004

Collaborators

Detail Information

Publications4

  1. ncbi Pyridoxine-induced toxicity in rats: a stereological quantification of the sensory neuropathy
    Tracy Ann Perry
    Section of Drug Design and Development, Laboratory of Neurosciences, Gerontology Research Center, National Institute on Aging NIH, 5600 Nathan Shock Drive, Baltimore, MD 21224, USA
    Exp Neurol 190:133-44. 2004
    ..This combined stereological and electrophysiological method demonstrates a general approach that could be used for assessing the correlation between pathophysiological and functional parameters in animal models of toxic neuropathy...
  2. ncbi Thalidomide-based TNF-alpha inhibitors for neurodegenerative diseases
    Nigel H Greig
    Drug Design and Development Section, Lab of Neurosciences, Intramural Research Prog, National Inst on Aging, National Inst of Health, 5600 Nathan Shock Dr, Baltimore, MD 21224, USA
    Acta Neurobiol Exp (Wars) 64:1-9. 2004
    ....
  3. ncbi Thiothalidomides: novel isosteric analogues of thalidomide with enhanced TNF-alpha inhibitory activity
    Xiaoxiang Zhu
    Drug Design and Development Section, Laboratory of Neurosciences, Gerontology Research Center (4E02, Intramural Research Program, National Institute on Aging, National Institutes of Health, 5600 Nathan Shock Dr, Baltimore, Maryland 21224-6825, USA
    J Med Chem 46:5222-9. 2003
    ..In addition, an intact phthalimido moiety appeared to be requisite for TNF-alpha inhibitory activity...
  4. ncbi A new Alzheimer's disease interventive strategy: GLP-1
    Tracy Ann Perry
    Drug Design and Development Section, Laboratory of Neurosciences, Gerontology Research Center, Intramural Research Program National Institute on Aging, National Institutes of Health, 5600 Nathan Shock Drive, Baltimore, MD 21224, USA
    Curr Drug Targets 5:565-71. 2004
    ..This review will consider the potential therapeutic relevance of GLP-1 to CNS disorders, such as AD...